These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 162144

  • 21. Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis.
    Berrih S, Morel E, Gaud C, Raimond F, Le Brigand H, Bach JF.
    Neurology; 1984 Jan; 34(1):66-71. PubMed ID: 6228745
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Pathogenesis and pathophysiology of myasthenia gravis--the role of thymus in myasthenia gravis (author's transl)].
    Ohshima F.
    No To Shinkei; 1980 Sep; 32(9):909-19. PubMed ID: 7437164
    [No Abstract] [Full Text] [Related]

  • 25. Suppressor T cells in myasthenia gravis and antibodies to acetylcholine receptor.
    Lisak RP, Laramore C, Levinson AI, Zweiman B, Moskovitz AR.
    Ann Neurol; 1986 Jan; 19(1):87-9. PubMed ID: 2936299
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The intrathymic pathogenesis of myasthenia gravis.
    Levinson AI, Song D, Gaulton G, Zheng Y.
    Clin Dev Immunol; 2004 Jan; 11(3-4):215-20. PubMed ID: 15559366
    [Abstract] [Full Text] [Related]

  • 29. Experimental autoimmune myasthenia gravis.
    Lindstrom J.
    J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):568-76. PubMed ID: 6249892
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Suppressor T cells in myasthenia gravis.
    Clementi F, Gotti C, Mori L, Ricciardi-Castagnoli P.
    Monogr Allergy; 1988 Jul; 25():41-9. PubMed ID: 2971877
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Significance of acetylcholine receptor antibody in the diagnosis and therapy monitoring of myasthenia gravis.
    Heininger K, Fateh-Moghadam A, Toyka KV, Besinger UA, Witthöft J.
    Ric Clin Lab; 1980 Jul; 10(1):255-8. PubMed ID: 7008156
    [No Abstract] [Full Text] [Related]

  • 36. The thymus and myasthenia gravis.
    Ragheb S, Lisak RP.
    Chest Surg Clin N Am; 2001 May; 11(2):311-27, x. PubMed ID: 11413758
    [Abstract] [Full Text] [Related]

  • 37. [Physiopathology of myasthenia gravis. A review (author's transl)].
    Bergmans J.
    Ann Chir; 1980 Mar; 34(3):147-57. PubMed ID: 6245616
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. No direct correlation between serum antiacetylcholine receptor antibody levels and clinical state of individual patients with myasthenia gravis.
    Roses AD, Olanow CW, McAdams MW, Lane RJ.
    Neurology; 1981 Feb; 31(2):220-4. PubMed ID: 7193309
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.